Long-term function of islets encapsulated in a redesigned alginate microcapsule construct in omentum pouches of immune-competent diabetic rats

Pancreas

Volumn 43, Issue 4, 2014, Pages 605-613

  Pareta, Rajesh ^a   McQuilling, John P ^a   Sittadjody, Sivanandane ^a   Jenkins, Randy ^a   Bowden, Stephen ^a   Orlando, Giuseppe ^a   Farney, Alan C ^a   Brey, Eric M ^b,c   Opara, Emmanuel C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Illinois Institute of Technology   (United States)

^c HINES VA HOSPITAL   (United States)

Author keywords

Alginate; Allotransplantation; Immunoisolation; Islets; Microencapsulation; Omentum

Indexed keywords

ALGINIC ACID; C PEPTIDE; FIBROBLAST GROWTH FACTOR 1; GLUCOSE; MANNURONIC ACID; ANGIOGENIC FACTOR; GLUCOSE BLOOD LEVEL; GLUCURONIC ACID; HEXURONIC ACID;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; BODY WEIGHT; CELL ENCAPSULATION; CONFERENCE PAPER; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT RECIPIENT; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; ISOLATION AND PURIFICATION; LEWIS RAT; MALE; MICROCAPSULE; NONHUMAN; OMENTUM; PANCREAS ISLET; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANGIOGENESIS; ANIMAL; BLOOD; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; GRAFT SURVIVAL; IMMUNOCOMPETENCE; IMMUNOLOGY; METABOLISM; PANCREAS ISLET TRANSPLANTATION; PROCEDURES; SURGERY; TIME; TISSUE SCAFFOLD; VASCULARIZATION; WISTAR RAT;

ALGINATES; ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOOD GLUCOSE; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; FIBROBLAST GROWTH FACTOR 1; GLUCURONIC ACID; GRAFT SURVIVAL; HEXURONIC ACIDS; IMMUNOCOMPETENCE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OMENTUM; RATS, INBRED LEW; RATS, WISTAR; TIME FACTORS; TISSUE SCAFFOLDS;

EID: 84898439938     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000107     Document Type: Conference Paper

References (46)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
2. Matsumoto S. Islet cell transplantation for type 1 diabetes. J of Diabetes. 2010;2:16-22.
3. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care. 2012;35:1436-1445.
4. Ludwig B, Rotem A, Schmid J, et al. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci. 2012; 109:5022-5027.
5. Fort A, Fort N, Ricordi C, et al. Biohybrid devices and encapsulation technologies for engineering a bioartificial pancreas. Cell Transplant. 2008;17:997-1003.
6. Lim F, Sun A. Microencapsulated islets as bioartificial pancreas. Science. 1980;210:908-910.
7. Uludag H, de Vos P, Tresco PA. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev. 2000;42:29-64.
8. Darrabie MD, Kendall WF, Opara EC. Characteristics of poly-L-ornithine-coated alginate microcapsules. Biomaterials. 2005;26:6846-6852.
9. Opara EC, Mirmalek-Sani S-H, Khanna O, et al. Design of a bioartificial pancreas. J Investig Med. 2010;58:831-837.
10. Sakai S, Inagaki H, Inamoto K, et al. Wrapping tissues with a pre-established cage-like layer composed of living cells. Biomaterials. 2012;33:6721-6727.
11. Temura Y, Oommen OP, Olerud J, et al. Microencapsulation of cells, including islets, within stable ultra-thin membranes of maleimide-conjugated PEG-lipid with multi-functional crosslinkers. Biomaterials. 2013;34:2683-2693.
12. McQuilling JP, Arenas-Herrera J, Childers C, et al. New alginate microcapsule system for angiogenic protein delivery and immunoisolation for transplantation in the rat omentum pouch. Transplant Proc. 2011;43:3262-3264.
13. Davis NE, Beenken-Rothkopf LN, Mirsoian A, et al. Enhanced function of pancreatic islets co-encapsulated with ECM proteins and mesenchymal stromal cells in a silk hydrogel. Biomaterials. 2012;33:6691-6697.
14. Liao SW, Rawson J, Omori K, et al. Maintaining functional islets through encapsulation in an injectable saccharide-peptide hydrogel. Biomaterials. 2013;34:3984-3991.
15. Phelps EA, Headen DM, Taylor WR, et al. Vasculogenic biosynthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes. Biomaterials. 2013;34:4602-4611.
16. Barkai U, Weir GC, Colton CK, et al. Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. Cell Transplant. 2013;22:1463-1476.
17. Jansson L, Hellerstrom C. Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia. 1983;25:45-50.
18. Lifson N, Lassa CV, Dixit PK. Relation between blood flow and morphology in islet organ of rat pancreas. Am J Physiol. 1985;249:E43-E48.
19. Dionne KE, Colton CK, Yarmush ML. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes. 1993;42:12-21.
20. Halberstadt CR, Williams D, Emerich D, et al. Subcutaneous transplantation of islets into streptozocin-induced diabetic rats. Cell Transplant. 2005;14:595-605.
21. Cantley J, Walters SN, Jung MH, et al. A pre-existent hypoxic gene signature predicts impaired islet graft function and glucose homeostasis. Cell Transplant. 2013;22:2147-2159.
22. Kim HI, Yu JE, Park CG, et al. Comparison of four pancreatic islet implantation sites. J Korean Med Sci. 2009;25:203-210.
23. Yang KC, Wu CC, Qi Z, et al. Comparison of bioartificial pancreas performance in the bone marrow cavity and intramuscular space. Arch Med Res. 2010;41:151-153.
24. Cantarelli E, Piemonti L. Alternative transplantation sites for pancreatic islet grafts. Curr Diab Rep. 2011;11:364-374.
25. Kobayashi T, Aomatsu Y, Hiroo I, et al. Survival of microencapsulated islets at 400 days posttransplantation in the omental pouch of NOD mice. Cell Transplant. 2006;15:359-365.
26. van der Windt DJ, Echeverri GJ, Ijzermans JN, et al. The choice of anatomical site for islet transplantation. Cell Transplant. 2008;17:1005-1014.
27. Berman D.M, O?Neil JJ, Coffey LC, et al. Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant. 2009;9:91-104.
28. Jacobs-Tulleneers-Thevissen D, Bartholomeus K, Suenens K, et al. Human islet cell implants in a nude rat model of diabetes survive better in omentum than in liver with a positive influence of beta cell number and purity. Diabetologia. 2010;53:1690-1699.
29. Kriz J, Vilk G, Mazzuca DM, et al. A novel technique for the transplantation of pancreatic islets within a vascularized device into the greater omentum to achieve insulin independence. Am J Surg. 2010;203:793-797.
30. Hefty TR, Kuhr CS, Chong KT, et al. Omental roll-up: a technique for islet engraftment in a large animal model. J Surg Res. 2010;61:134-138.
31. Lacy PE, Kostianovsky M. Method for the isolation of intact islets from the pancreas. Diabetes. 1967;16:35-39.
32. Field J, Farney A, Sutherland DE. Improved islet isolation from rat pancreas using 35% bovine serum albumin in combination with dextran gradient separation. Transplantation. 1996;61:1554-1556.
33. Khanna O, Moya ML, Opara EC, et al. Synthesis of multi-layered alginate microcapsules for the sustained release of fibroblast growth factor-1. J Biomed Mater Res A. 2010;95:632-640.
34. Tendulkar S, Mirmalek-Sani S-H, Childers C, et al. A three-dimensional microfluidic approach to scaling up microencapsulation of cells. Biomed Microdevices. 2012;14:461-469.
35. Goss JA, Flye MW, Lacy PE. Induction of allogeneic islet survival by intrahepatic islet preimmunization and transient immunosuppression. Diabetes. 1996;45:144-147.
36. O?Sullivan ES, Vegas A, Anderson DG, et al. Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr Rev. 2011;32:827-844.
37. Tam SK, Bilodeau S, Dusseault J, et al. Biocompatibility and physicochemical characteristics of alginate-polycation microcapsules. Acta Biomater. 2011;7:1683-1692.
38. Ponce S, Orive G, Hernandez R, et al. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials. 2006;27:4831-4839.
39. Hillberg AL, Kathirgamanathan K, Lam JB, et al. Improving alginate-poly-L-ornithine-alginate capsule biocompatibility through genipin crosslinking. J Biomed Mater Res B Appl Biomater. 2013;101:258-268.
40. Living Cell Technologies. Available at: www.lctglobal.com. Accessed December 22, 2012.
41. Goldsmith HS, Griffith AL, Kupferman A, et al. Lipid angiogenic factor from omentum. JAMA. 1984;252:2034-2036.
42. Veriter S, Gianello P, Igarashi Y, et al. Improvement of subcutaneous bioartificial pancreas vascularization and function by co-encapsulation of pig islets and mesenchymal stem cells in primates [published online ahead of print]. Cell Transplant. 2013.
43. Smidsrød O, Skjåk-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol.1990;8:71-78.
44. Duvillié B. Vascularization of the pancreas: an evolving role of embryogenesis to adulthood. Diabetes. 2013;62:4004-4005.
45. Reinert RB, Brissova M, Shostak A, et al. Vascular endothelial growth factor-A and islet vascularization are necessary in developing, but no adult pancreatic islets. Diabetes. 2013;62:4154-4164.
46. D?Hoker J, de Leu N, Heremans Y, et al. Conditional hypovascularization and hypoxia in islets do not overtly influence adult A-cell mass or function. Diabetes. 2013;62:4165-4173.